Co-Authors
This is a "connection" page, showing publications co-authored by Arturo Casadevall and DeLisa Fairweather.
Connection Strength
0.930
-
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses. 2021 08 11; 13(8).
Score: 0.240
-
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19. N Engl J Med. 2021 03 18; 384(11):1015-1027.
Score: 0.231
-
Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020 09 01; 130(9):4791-4797.
Score: 0.225
-
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors. Nat Commun. 2021 08 11; 12(1):4864.
Score: 0.060
-
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence. Front Med (Lausanne). 2021; 8:684151.
Score: 0.059
-
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc. 2021 05; 96(5):1262-1275.
Score: 0.058
-
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients. Mayo Clin Proc. 2020 09; 95(9):1888-1897.
Score: 0.056